Brazikumab
Product Specifications
CAS Number
1610353-18-8
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.98
Bioactivity
Brazikumab (AMG 139) is a humanized antibody targeting IL-23 by binding to the P19 subunit. It is a selective IL23p19 antagonist and can be used in Crohn's disease research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
